Six things to know:
1. Mr. Hanson’s 2019 compensation was $11.7 million. In April 2020, the company announced he was forgoing his full salary to curb the financial impact of COVID-19.
2. He was named president and CEO of Zimmer Biomet in December 2017. In 2021, he was appointed chair of the board.
3. Under Mr. Hanson’s leadership, Zimmer Biomet’s surgical robots have gained traction and grown in recent years. The Rosa partial knee system was completed, and the Rosa hip system received FDA approval.
4. Mr. Hanson has an estimated net worth of at least $26.2 million, according to wallmine.
5. Mr. Hanson is a former Medtronic executive and was executive vice president and group president of the company’s minimally invasive therapies segment. He also worked as group president for Covidien.
6. He attended Florida State University in Tallahassee where he studied finance, and completed leadership and executive programs at Northwestern University’s Kellogg School of Management in Chicago and Harvard Business School in Boston.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
